Culture LL-F28249, identified as Streptomyces cyaneogriseus sp. noncyanogenus, produces a new family of antiparasitic macrocyclic lactones. Characteristics of the producing organism and conditions for its fermentation were described in a preceding publication.1} Wepreviously reported the structures of the major bioactive compounds derived from the culture, LL-F28249 a, /3, y and I (1~4) in a brief communication,2) which included an X-ray structure determination of? (3). These compounds contain the macrocycle, the fused cyclohexene -tetrahydrofuran ring system, and bicyclic 6,6-spiroketal found in milbemycins3) and avermectins.4) Unique unsaturated side chains extending from position 25 are the structural features which differentiate 1~4 from milbemycins and the aglycone portion of avermectins. These extended unsaturated side chains are manifestations of a fundamental difference in the biosynthesis of the LLti#24y compounds. Uur experiments0' nave shown that the polyketide precursor of 1 is composed of 14 acyl units as opposed to the precursors of the milbemycins6) and avermectins70 which contain only 13 acyl units. The additional unit of the LL-F28249 precursor becomes the terminal portion of the characteristic side chains. LL-F28249 a (1), the main component, controls experimental infections of Trichostrongylus colubriformis in the gerbil with single oral doses of 0.2 mg/kg. Antiparasitic efficacy will be the subject of a separate report.
In this paper are described the isolation, chromatographic purification and structure determination of the four maior TJ,-F28249 com-
The name nemadectin has recently been approved for LL-F28249# by the USANCouncil.
ponents a (1), /S (2), r (3) and X (4).
Fermentati on
Materials and Methods APR. 1988 As described in a preceding publication,x) inoculum was prepared from frozen vegetative growth maintained at -80°C. The seed medium employed (g/liter) glucose 10, dextrin 20, yeast extract 5, NZ-AmineA 5, and CaCO31. Three successive stages of 24 hours incubation at 28°C were used to prepare 300 liters of inoculum for the production tank. The inoculum was introduced into 3,000 liters of the sterilized production medium consisting of (g/liter) glucose 50, cottonseed flour (Pharmamedia) 25 and CaCO37. The tank was maintained at 30°C, agitation was provided by an impeller driven at 120 rpm9 and aeration was supplied at 1,950 liters of air per minute. At 128 hours the titer of LL-F28249 a had risen to 575 jug/ml by HPLCanalysis and the tank was harvested for processing.
Processing
The fermentation broth (3,000 liters) was stirred with toluene (30 liters) for 30 minutes to kill the cells. Diatomaceous earth (Celite 512, 50kg) was added with agitation followed by filtration. The resulting cake was washed with H2O(100 liters) and both filtrate and wash were discarded. MeOH (1,500 liters) was used to extract the washed cake. The MeOHextract was concentrated to approximately 200 liters under reduced pressure and the resulting concentrate was mixed with an equal volume of methylene chloride. The methylene chloride phase was separated and concentrated under reduced pressure to 1.5 liters.
Chromatographic Purification A portion of the crude methylene chloride concentrate (100 ml) was chromatographed on silica gel (600 g, 55~105 pm) eluted with EtOAc-hexane (1 :9). The flow rate was 200ml/minute and fractions were collected at 2 minute intervals. On the basis of HPLCanalysis, fractions 3O~5O were combined to give 8.2 g of material (designated preparation I) upon evaporation of the solvents. Similarly fractions 58~80 were combined yielding preparation II (15.8 g).
Preparation I (8.0 g) was subjected to reversed-phase chromatography on C18 bonded-phase silica (800g, 55~105 /urn) eluted with MeOH-water (3 : 1). The flow rate was 150ml/minute and fractions were collected at 2.5 minute intervals. Fractions 37~46 were combined, concentrated under reduced pressure, and the residual aqueous solution was extracted with methylene chloride. Evaporation of the methylenechloride gave a colorless residue which was redissolved in tert-butanol and freeze-dried yielding LL-F28249 j (3, 2.2 g), as a white fluffy solid. Fractions 72~81 were combined and processed in the same manner to give LL-F28249 X (4, 1.4 g).
Preparation II was chromatographed using the same reversed-phase system. Combining fractions 21 -26 yielded LL-F28249 /3 (2, 0.17 g) and fractions 32-54 gave LL-F28249 a (1, ll.1 g).
Analytical HPLC Reversed-phase HPLCwas used to monitor fermentation titers and to guide the processing and chromatographic purification steps. The system consisted of a C18 bonded-phase column (5 /urn, 2.1 x 100 mm)developed with 73% MeOH-water at 0.8 ml/minute. Detection was by UVabsorbance at 244 nm. A typical chrornatogram of the crude extract of the culture is shown in Fig. 1 . Instrumental 2H and 13C NMRspectra were recorded on either a Nicolet NT300WB or General Electric QE300 spectrometer. High resolution (HR) mass spectral data were obtained with a VGAnalytical ZAB-SE instrument.
Results and Discussion
The isolation and purification scheme used to obtain LL-F28249 a, B, r and /I (1~4) is outlined in Fig. 2 . The macrolides were recovered from the cells with methanol and were subsequently purified by chromatography on silica gel and C18 reversed-phase columns.
White fluffy solids were obtained for 1~4
by freeze-drying from ter/-butanol. These substances dissolve readily in all commonorganic solvents and are practically insoluble in water.
Asummaryof selected physico-chemical properties is presented in Table 1 . The molecular formulas were determined from the measured masses of their molecular ions (M+), obtained by HR electron impact mass spectrometry (EI-MS). All of the compounds are optically active and contain a maximumin their UV absorption spectra at 244 nm with shoulders at approximately 235 and 255nm. The IR spectra of the compounds are similar, each showing a related series of strong bands. The UV, IR, 2H NMRand 13C NMRspectra for 1 are reproduced in Figs. 3-6 , respectively.
The relationship of LL-F28249 a, /3, y and 1 (1-4) to the milbemycins was initially recognized by the appearance of characteristic fragment ions in their EI-MS. Structurally significant fragment ions are represented in Fig. 7 . Ions at mjz 151, 248 and 314 were observed in the spectra of 1-4 (ions a, e and f, Fig. 7) ; these have previously been described for milbemycins al9 az and D.8) The observation of ions of type d provided evidence for the macrocycle and suggested the presence of the substructural unit C-l through C-21 as shown.
Further evidence for this partial structure was obtained by comparison of 13C NMR data with (14) 219 (8) assignments made for milbemycin D6) ( Table 2) . Excellent correlation1 of the C-l~C-21 chemical shifts was noted for 1 and 2 with some minor changes observed for methoxy derivatives 3 and 4. On the basis of these data, it was concluded that the carbon skeleton from C-l to C-21 was the same in 1~4 and that 3 and 4 represented (Fig. 7) and not for ions a, c, e, orf. The structurally novel features of 1~4 are contained in the remainder of the molecules, consisting of CnH20O2for 1 and 4 and C9H16O2for 2 and 3. In each case, a tetrahydropyran ring is formed by C-21~C-25 and the remaining ketal oxygen. The substitution of this ring was established through spectroscopic analysis. In the EI-MS of 1~4 appearance of the ion at mjz 314 (Fig. 7 , type e) was strong evidence for a methylene group at position 22. Hydroxy substitution at C-23 was indicated by EI-MS ions of type b. These presumably arise by initial dehydration to the J22 compounds followed by retro Diels-Alder fragmentation. Methyl substitution at C-24 is supported by the elemental compositions of the b ions. This methyl group (24a) gives rise to the highest-field signal in the XHNMRspectra of the molecules (Table 3) , which correlates with 13C NMRsignals between 8 13.7-13.9 ( Table 2 ).
The unique unsaturated side chains at position 25 were defined by analysis of NMRdata. In the case of 1, the trisubstituted olefin was recognized by 13C NMRsignals at 8 130.6 (s) C-26 and 137.2 (d) C-27. Placement of the isopropyl and methyl substituents about the double bond was established by *H NMR(/H27>28=9.1 Hz) and XH correlation spectroscopy (COSY) experiments. The olefinic proton 27-H was shown by COSYto be coupled to the 28-H methine proton at 8 2.58 which was in turn linked to 2 methyl groups at 8 0.953 and 1.05 (CH3 28a and 29). Coupling was also indicated between 27-H and CH3-26a.nThe magnitude of this coupling is quite small as no splitting of the signals was observed. The same general pattern was seen for 4 (Table 3) . Allylic coupling was indicated between 27-H and CH3-26a and in this case, both XHNMRsignals show additional splitting.
For compounds 2 and 3, EI-MS ions of types g, h, i, j, k and 1 (Fig. 7) clearly showedtheir side chains to be C2H4 less than that of 1 and 4. Replacement of the isopropyl group at C-27 with a methyl group explains the nature of this homology. The terminal olefinic methyl groups give rise to doublets at 8 1.66 in the XHNMRspectra of2 and 3 (Table 3 ). The signal due to the olefinic proton (27-H) appears at 3 5.47 in both spectra as a broadened quartet. Someallylic coupling to CH3-26a appears to be responsible for the broadened nature of these signals.
Wesuggest a revision of the 13C NMR assignments for milbemycins a2i a^and D made in ref 6. On the basis of XH COSYand two-dimensional (2D) 1H, 13C correlation spectroscopy, we have consistently found the signal for C-19 at higher field than that for C-17. In addition, for compounds 1 and 2 the resonance attributed to C-5 is at higher field than either that of C-17 or C-19. Webelieve the correct assignments for milbemycin D should be C-5 (67.4), C-17 (68.7) and C-19 (67.8). For milbemycins a2 and a4 the assignments of C-17 and C-19 should be reversed. In our original communication (ref 2) this coupling was mistakenly attributed to a long-range interaction between 25-H and 27-H. APR. 1988 The relative stereochemistry shown for these molecules is that found for the j component 3 by X-ray crystallography. Lett. 28: 5353~5356, 1987) reported to have independently isolated compounds identical with LL-F28249 a, ft y and X.
Also, a refinement of the NMRassignments has been completed by our colleague Dr. S. Rajan. This work will be published separately in the near future. 
